![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach:
Dokumententyp
| Veröffentlichungsdatum
Springe zu: Zeitschriftenartikel
Anzahl der Publikationen: 14
Zeitschriftenartikel
Hänel, Gerulf; Angerer, Caroline; Petry, Katja; Lichtenegger, Felix S. und Subklewe, Marion
(2021):
Blood DCs activated with R848 and poly(I:C) induce antigen-specific immune responses against viral and tumor-associated antigens.
In: Cancer immunology, immunotherapy : CII
[PDF, 3MB]
Augsberger, Christian; Hanel, Gerulf; Xu, Wei; Pulko, Vesna; Hanisch, Lydia Jasmin; Augustin, Angelique; Challier, John; Hunt, Katharina; Vick, Binje; Rovatti, Pier Eduardo; Krupka, Christina; Rothe, Maurine; Schonle, Anne; Sam, Johannes; Lezan, Emmanuelle; Ducret, Axel; Ortiz-Franyuti, Daniela; Walz, Antje-Christine; Benz, Jorg; Bujotzek, Alexander; Lichtenegger, Felix S.; Gassner, Christian; Carpy, Alejandro; Lyamichev, Victor; Patel, Jigar; Konstandin, Nikola; Tunger, Antje; Schmitz, Marc; Bergwelt-Baildon, Michael von; Spiekermann, Karsten; Vago, Luca; Jeremias, Irmela; Marrer-Berger, Estelle; Umana, Pablo; Klein, Christian und Subklewe, Marion
(2021):
Targeting intracellular WT1 in AML with a novel RMF-peptide-MHC-specific T-cell bispecific antibody.
In: Blood, Bd. 138, Nr. 25: S. 2655-2669
Haenel, Gerulf; Angerer, Caroline; Petry, Katja; Lichtenegger, Felix S. und Subklewe, Marion
(2021):
Blood DCs activated with R848 and poly(I:C) induce antigen-specific immune responses against viral and tumor-associated antigens.
In: Cancer Immunology Immunotherapy, Bd. 71, Nr. 7: S. 1705-1718
Lichtenegger, Felix S.; Schnorfeil, Frauke M.; Rothe, Maurine; Deiser, Katrin; Altmann, Torben; Bücklein, Veit L.; Köhnke, Thomas; Augsberger, Christian; Konstandin, Nikola P.; Spiekermann, Karsten; Moosmann, Andreas; Boehm, Stephan; Boxberg, Melanie; Heemskerk, Mirjam H. M.; Goerlich, Dennis; Wittmann, Georg; Wagner, Beate; Hiddemann, Wolfgang; Schendel, Dolores J.; Kvalheim, Gunnar; Bigalke, Iris und Subklewe, Marion
(2020):
Toll‐like receptor 7/8‐matured RNA‐transduced dendritic cells as post‐remission therapy in acute myeloid leukaemia: results of a phase I trial.
In: Clinical & Translational Immunology, Bd. 9, Nr. 3, e1117
[PDF, 1MB]
Schwaab, Juliana; Naumann, Nicole; Luebke, Johannes; Jawhar, Mohamad; Somervaille, Tim C. P.; Williams, Mark S.; Frewin, Rebecca; Jost, Philipp J.; Lichtenegger, Felix S.; La Rosee, Paul; Storch, Nicola; Haferlach, Torsten; Horny, Hans-Peter; Fabarius, Alice; Haferlach, Claudia; Burchert, Andreas; Hofmann, Wolf-Karsten; Cross, Nicholas C. P.; Hochhaus, Andreas; Reiter, Andreas und Metzgeroth, Georgia
(2020):
Response to tyrosine kinase inhibitors in myeloid neoplasms associated with PCM1-JAK2, BCR-JAK2 and ETV6-ABL1 fusion genes.
In: American Journal of Hematology, Bd. 95, Nr. 7: S. 824-833
Ruzicka, Michael; König, Lars M.; Formisano, Simone; Boehmer, Daniel F. R.; Vick, Binje; Heuer, Eva-M.; Meinl, Hanna; Kocheise, Lorenz; Zeitlhoefler, Marcus; Ahlfeld, Julia; Kobold, Sebastian; Endres, Stefan; Subklewe, Marion; Duewell, Peter; Schnurr, Max; Jeremias, Irmela; Lichtenegger, Felix S. und Rothenfusser, Simon
(2020):
RIG-I-based immunotherapy enhances survival in preclinical AML models and sensitizes AML cells to checkpoint blockade.
In: Leukemia, Bd. 34, Nr. 4: S. 1017-1026
Van Acker, Heleen H.; Versteven, Maarten; Lichtenegger, Felix S.; Roex, Gils; Campillo-Davo, Diana; Lion, Eva; Subklewe, Marion; Van Tendeloo, Viggo F.; Berneman, Zwi N. und Anguille, Sebastien
(2019):
Dendritic Cell-Based Immunotherapy of Acute Myeloid Leukemia.
In: Journal of Clinical Medicine, Bd. 8, Nr. 5, 579
Lichtenegger, Felix S.; Rothe, Maurine; Schnorfeil, Frauke M.; Deiser, Katrin; Krupka, Christina; Augsberger, Christian; Schlueter, Miriam; Neitz, Julia und Subklewe, Marion
(2018):
Targeting LAG-3 and PD-1 to Enhance T Cell Activation by Antigen-Presenting Cells.
In: Frontiers in Immunology, Bd. 9, 385
[PDF, 1MB]
Lichtenegger, Felix S.; Krupka, Christina; Haubner, Sascha; Koehnke, Thomas und Subklewe, Marion
(2017):
Recent developments in immunotherapy of acute myeloid leukemia.
In: Journal of Hematology & Oncology
10:142
[PDF, 879kB]
Krupka, Christina; Lichtenegger, Felix S.; Kohnke, Thomas; Bogeholz, Jan; Bucklein, Veit; Roiss, Michael; Altmann, Torben; Do, To Uyen; Dusek, Rachel; Wilson, Keith; Bisht, Arnima; Terrett, Jon; Aud, Dee; Pombo-Villar, Esteban; Rohlff, Christian; Hiddemann, Wolfgang und Subklewe, Marion
(2017):
Targeting CD157 in AML using a novel, Fc-engineered antibody construct.
In: Oncotarget, Bd. 8, Nr. 22: S. 35707-35717
[PDF, 1MB]
Lichtenegger, Felix S.; Schnorfeil, Frauke M.; Köhnke, Thomas; Altmann, Torben; Bücklein, Veit; Moosmann, Andreas; Brüggemann, Monika; Wagner, Beate; Hiddemann, Wolfgang; Bigalke, Iris; Kvalheim, Gunnar und Subklewe, Marion
(2016):
Next-generation dendritic cell vaccination in postremission therapy of AML: Results of a clinical phase I trial.
In: Cancer Immunology Research, Bd. 4, Nr. 1
Kocabey, Samet; Meinl, Hanna; MacPherson, Iain S.; Cassinelli, Valentina; Manetto, Antonio; Rothenfusser, Simon; Liedl, Tim und Lichtenegger, Felix S.
(2015):
Cellular Uptake of Tile-Assembled DNA Nanotubes.
In: Nanomaterials, Bd. 5, Nr. 1: S. 47-60
[PDF, 1MB]
Schnorfeil, Frauke M.; Lichtenegger, Felix S.; Emmerig, Katharina; Schlueter, Miriam; Neitz, Julia S.; Draenert, Rika; Hiddemann, Wolfgang und Subklewe, Marion
(2015):
T cells are functionally not impaired in AML: increased PD-1 expression is only seen at time of relapse and correlates with a shift towards the memory T cell compartment.
In: Journal of Hematology & Oncology
8:93
[PDF, 2MB]
Beck, Barbara; Doerfel, Daniela; Lichtenegger, Felix S.; Geiger, Christiane; Lindner, Lysann; Merk, Martina; Schendel, Dolores J. und Subklewe, Marion
(2011):
Effects of TLR agonists on maturation and function of 3-day dendritic cells from AML patients in complete remission.
In: Journal of Translational Medicine
9:151
[PDF, 547kB]